ASYLIA THERAPEUTICS
Asylia Therapeutics is a biotech company focused on novel immune-modulating therapies for autoimmune, cancer, and infectious diseases. The company's platform centers on a drug pipeline capable of modulating antigen presentation to the immune system which has produced unprecedented anti-tumor responses across multiple cancer models. Asylia Therapeutics was founded in 2019 in Houston, Texas.
ASYLIA THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2019-01-01
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.asyliatx.com
Total Employee:
1+
Status:
Active
Total Funding:
22.69 M USD
Technology used in webpage:
Domain Not Resolving U.S. Server Location
Similar Organizations
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Pathios Therapeutics
Pathios Therapeutics is a biotech company focused on the development of therapies for autoimmune diseases and cancer.
Current Employees Featured
Founder
Investors List
Sporos Bioventures
Sporos Bioventures investment in Series A - Asylia Therapeutics
Official Site Inspections
http://www.asyliatx.com
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Asylia Therapeutics"
Leadership – Asylia Therapeutics
Asylia’s experienced and diverse leadership team is driven by a common mission to transform breakthrough science into highly effective medicines for patients suffering from cancer, autoimmune and infectious diseases. Our multi …See details»
Company Overview – Asylia Therapeutics
Asylia Therapeutics is a private development stage biotechnology company committed to transforming scientific advances into safe and effective medicines for cancer and auto-immune diseases. Founded in 2019 and based in …See details»
Asylia Therapeutics - Crunchbase Company Profile
Asylia Therapeutics is a biotech company focused on novel immune-modulating therapies for autoimmune, cancer, and infectious diseases.See details»
Asylia Therapeutics | LinkedIn
Asylia Therapeutics is a private development stage biotechnology company committed to transforming scientific advances into safe and effective medicines for cancer and auto-immune …See details»
Asylia Therapeutics - VentureRadar
"Asylia Therapeutics is a private development stage biotechnology company committed to transforming scientific advances into safe and effective medicines for cancer and auto-immune …See details»
Asylia Therapeutics - Company Profile - Tracxn
Dec 5, 2024 Asylia Therapeutics - Developer of medicines for cancer, autoimmune, and infectious diseases. Raised a total funding of $14.5M over 1 round from 1 investor.See details»
Asylia Therapeutics Company Profile 2024: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for Asylia Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Asylia Announces Formation of Distinguished Scientific Advisory …
HOUSTON, July 22, 2021 – Asylia Therapeutics (“Asylia”), a development-stage biotechnology company advancing novel immune modulating therapies for cancer and autoimmune …See details»
Asylia Therapeutics, Inc. in Houston, TX - (713) 304-7746 - Profile
Asylia Therapeutics is located in Houston, Texas. This organization primarily operates in the Commercial Physical Research business / industry within the Engineering, Accounting, …See details»
Asylia Therapeutics, Inc. Announces Closing of $14.5 Million Series …
May 25, 2021 To learn more, visit www.asyliatx.com ABOUT SPOROS BIOVENTURES Sporos is transforming knowledge into new hope for patients.See details»
Asylia Therapeutics, Inc. - ContactOut
Asylia Therapeutics, established August 6, 2019, is a private, development-stage biotechnology company advancing novel immune modulating therapies for cancer and autoimmune …See details»
Asylia Therapeutics - Overview, News & Similar companies
Jun 2, 2021 View Asylia Therapeutics (www.asyliatx.com) location in Texas, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
CPRIT AWARDS $3 MILLION TO ASYLIA THERAPEUTICS - BioSpace
Jun 11, 2020 Asylia Therapeutics (“Asylia”), a Texas-based, privately held, development-stage biopharmaceutical company developing novel immune modulating therapies for cancer, …See details»
New Company Asylia Therapeutics Finalizes Exclusive Worldwide …
New Company Asylia Therapeutics Finalizes Exclusive Worldwide License Agreement Asylia Therapeutics (“Asylia”), a new, privately-held, development stage biopharmaceutical company, …See details»
Asylia Therapeutics (Biotechnology - United States) - Competitors ...
Description Asylia Therapeutics specializes in innovative biopharmaceuticals, focusing on a unique drug pipeline that enhances antigen presentation to the immune system. This …See details»
Asylia Therapeutics - workinbiotech.com
Asylia Therapeutics is developing immune-modulating therapies for the treatment of autoimmune, cancer and infectious diseases. The fundamental mechanism of immunity is the presentation …See details»
Our Story – Asylia Therapeutics
© 2024 Asylia Therapeutics, Inc., All Rights Reserved Scroll to TopSee details»
ASY-77A - Drug Targets, Indications, Patents - Synapse
To learn more, visit www.asyliatx.com Sporos is transforming knowledge into new hope for patients. With deep roots in Texas, connections within Texas Medical Center (TMC), and …See details»
Asylia Therapeutics, Inc. Announces Closing of $14.5 Million Series …
May 25, 2021 The company’s platform centers on a drug pipeline capable of modulating antigen presentation to the immune system which has, to date, produced anti-tumor responses across …See details»